Medicinal attributes of pyridine scaffold as anticancer targeting agents

被引:59
|
作者
Mohamed, Esraa Ali [1 ]
Ismail, Nasser S. M. [2 ]
Hagras, Mohamed [3 ]
Refaat, Hanan [1 ]
机构
[1] Future Univ Egypt, Fac Pharmaceut Sci & Pharmaceut Ind, Dept Pharmaceut Chem, Cairo, Egypt
[2] Ain Shams Univ, Fac Pharm, Dept Pharmaceut Chem, Cairo, Egypt
[3] Al Azhar Univ, Fac Pharm, Dept Pharmaceut Chem, Cairo, Egypt
关键词
Pyridines; Anticancer; Cytotoxic action; Tyrosine kinases; NF-KAPPA-B; BIOLOGICAL EVALUATION; DERIVATIVES; DESIGN; CANCER; ANGIOGENESIS; INHIBITORS; CDK9; EGFR;
D O I
10.1186/s43094-020-00165-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: The heterocyclic compounds particularly pyridine displayed clinical and biological implementation. Pyridine scaffolds have been detected in most relevant drug molecules that included pyridine provided a great possibility for treatment. Main text: Pyridine-containing compounds have increasing importance for medicinal application as antiviral, anticholinesterase activities, antimalarial, antimicrobial, antidiabetic and anticancer. This has generated concern among researchers in synthesising a variety of pyridine derivatives. Conclusion: This review focuses on different pyridine targets as anticancer and their pharmacophoric elements controlling its activity.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] Diversely Functionalized Pyridine Ring-fused Heterocycles and their Anticancer Properties
    Narasimhamurthy, Kereyagalahally H.
    Girish, Yarabahally R.
    Swaroop, Toreshettahally R.
    Rangappa, Kanchugarakoppal S.
    LETTERS IN DRUG DESIGN & DISCOVERY, 2024, 21 (11) : 1904 - 1912
  • [42] A Therapeutic Journey of Pyridine-based Heterocyclic Compounds as Potent Anticancer Agents: A Review (From 2017 to 2021)
    Alrooqi, Munira
    Khan, Sikandar
    Alhumaydhi, Fahad A.
    Asiri, Saeed A.
    Alshamrani, Meshal
    Mashraqi, Mutaib M.
    Alzamami, Ahmad
    Alshahrani, Asma M.
    Aldahish, Afaf A.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2022, 22 (15) : 2775 - 2787
  • [43] Indole derivatives targeting colchicine binding site as potential anticancer agents
    Goel, Bharat
    Jaiswal, Shivani
    Jain, Shreyans K. K.
    ARCHIV DER PHARMAZIE, 2023, 356 (10)
  • [44] Design and Synthesis of Thiazole Scaffold-Based Small Molecules as Anticancer Agents Targeting the Human Lactate Dehydrogenase A Enzyme
    Sharma, Dolly
    Singh, Mamta
    Joshi, Jayadev
    Garg, Manoj
    Chaudhary, Vidhi
    Blankenberg, Daniel
    Chandna, Sudhir
    Kumar, Vinit
    Rani, Reshma
    ACS OMEGA, 2023, 8 (20): : 17552 - 17562
  • [45] 1,2,3-TRIAZOLE SCAFFOLD IN RECENT MEDICINAL APPLICATIONS: SYNTHESIS AND ANTICANCER POTENTIALS#
    Choomuenwai, Vanida
    Leechaisit, Ronnakorn
    Pingaew, Ratchanok
    Prachayasittikul, Veda
    Prachayasittikul, Supaluk
    Prachayasittikul, Virapong
    HETEROCYCLES, 2022, 105 (01) : 147 - 178
  • [46] Twisted amides based on the spirohydantoin scaffold as potential anticancer agents
    Lazic, Anita
    Surucic, Relja
    Stanisavljevic, Nada Grozdanic
    Popovic-Djordjevic, Jelena
    Banjac, Nebojsa
    Stanojkovic, Tatjana
    Trisovic, Nemanja
    JOURNAL OF MOLECULAR STRUCTURE, 2025, 1332
  • [47] Synthesis, anticancer activity and structure-activity relationship of some anticancer agents based on Cyclopenta (b) thiophene scaffold
    Said, Mohamed
    Elshihawy, Hosam
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 27 (04) : 885 - 892
  • [48] Structural tuning of acridones for developing anticancer agents targeting dihydrofolate reductase
    Singh, Harpreet
    Kaur, Manpreet
    Kaur, Harpreet
    Sharma, Indu
    Bhandari, Anmol
    Kaur, Gurcharan
    Singh, Palwinder
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (19)
  • [49] Pyridine-based chalcones as promising anticancer agents: Design, synthesis and in silico studies
    Sankhe, Sharad S.
    Mukadam, Vilas M.
    RESULTS IN CHEMISTRY, 2024, 9
  • [50] Recent Progress on Pyrazole Scaffold-Based Antimycobacterial Agents
    Keri, Rangappa S.
    Chand, Karam
    Ramakrishnappa, Thippeswamy
    Nagaraja, Bhari Mallanna
    ARCHIV DER PHARMAZIE, 2015, 348 (05) : 299 - 314